Company Filing History:
Years Active: 2010-2013
Title: Angela Cannas: Innovator in Viral Infection Diagnostics
Introduction
Angela Cannas is a prominent inventor based in Arbus, Italy. She has made significant contributions to the field of viral infection diagnostics, holding a total of 4 patents. Her work focuses on innovative methods for diagnosing and monitoring viral infections, which have the potential to improve patient outcomes.
Latest Patents
One of Angela Cannas' latest patents is a method for diagnosis and monitoring of viral infection by analysis of viral transrenal nucleic acids in urine. This invention relates to detecting the presence of transrenal viral nucleic acids or nucleic acids of viral origin in urine samples, with or without the isolation of nucleic acids. The analysis is performed through hybridization with specific probes or through a chain amplification reaction with specific primers. This method is applicable to all viral pathogenic agents, including RNA, DNA, episomal, or integrated viruses. Additionally, she has developed kits for diagnosis and monitoring of viral infection using the same innovative approach.
Career Highlights
Angela Cannas is associated with Trovagene, Inc., where she continues to advance her research and development efforts. Her work has garnered attention for its potential applications in clinical settings, particularly in the realm of infectious diseases.
Collaborations
Angela has collaborated with notable colleagues, including Hovsep S Melkonyan and Louis David Tomei, to further enhance her research initiatives.
Conclusion
Angela Cannas is a trailblazer in the field of viral infection diagnostics, with her innovative patents paving the way for improved diagnostic methods. Her contributions are vital in the ongoing fight against viral infections, showcasing the importance of innovation in healthcare.